DXCM RSI Chart
Last 7 days
2.1%
Last 30 days
-6.4%
Last 90 days
2.7%
Trailing 12 Months
8.2%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 3.8B | 0 | 0 | 0 |
2023 | 3.0B | 3.2B | 3.4B | 3.6B |
2022 | 2.6B | 2.7B | 2.8B | 2.9B |
2021 | 2.0B | 2.2B | 2.3B | 2.4B |
2020 | 1.6B | 1.7B | 1.8B | 1.9B |
2019 | 1.1B | 1.2B | 1.4B | 1.5B |
2018 | 760.6M | 832.5M | 914.6M | 1.0B |
2017 | 599.4M | 632.7M | 668.7M | 718.5M |
2016 | 445.4M | 489.8M | 534.2M | 573.3M |
2015 | 285.1M | 319.2M | 354.4M | 402.0M |
2014 | 177.1M | 200.1M | 226.2M | 259.0M |
2013 | 109.5M | 121.8M | 141.6M | 160.0M |
2012 | 82.2M | 84.3M | 89.1M | 100.0M |
2011 | 53.3M | 62.9M | 69.5M | 76.3M |
2010 | 34.4M | 39.2M | 43.9M | 48.6M |
2009 | 0 | 0 | 0 | 29.7M |
Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed S&P 500 Index
Grufity's Fair Value model takes all the S&P 500 stocks and divides them into separate buckets based on their attractiveness. The 'Very Cheap' bucket of S&P 500 has greatly outperformed S&P 500 Index. Conversely, S&P500 stocks considered 'Very Expensive' by the model underperformed the S&P500 index in the past three years. Grufity Fair Value is available for 2300+ stocks, including 90% of S&P 500 stocks. Grufity's Fair Value Model separates high-return stocks from low-return stocks.
Returns of $10,000 invested in:
Very Cheap Stocks: $17,289
S&P 500 Index: $12,922
Very Expensive Stocks: $11,022
Grufity's Fair Value model does a great job in separating High Performing Stocks from Low Performing ones in the S&P 500 list.
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Apr 30, 2024 | brown michael jon | sold | -79,411 | 126 | -629 | evp chief legal officer |
Apr 15, 2024 | dolan matthew vincent | sold | -274,242 | 137 | -1,990 | evp strategy and corporate dev |
Apr 08, 2024 | sayer kevin r | sold | -6,864,140 | 138 | -49,633 | president ceo and chairman |
Mar 28, 2024 | brown michael jon | sold | -367,472 | 140 | -2,624 | evp chief legal officer |
Mar 25, 2024 | stern sadie | sold | -579,180 | 140 | -4,137 | evp chief human resources |
Mar 15, 2024 | dolan matthew vincent | sold | -547,259 | 130 | -4,203 | evp strategy & corp dev |
Mar 12, 2024 | stern sadie | sold | -2,715,010 | 133 | -20,321 | evp chief human resources |
Mar 12, 2024 | dolan matthew vincent | sold | -901,896 | 134 | -6,710 | evp strategy and corporate |
Mar 12, 2024 | lawver teri l | sold | -640,333 | 134 | -4,764 | evp chief commercial officer |
Mar 12, 2024 | brown michael jon | sold | -1,182,680 | 134 | -8,799 | evp chief legal officer |
Which funds bought or sold DXCM recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 06, 2024 | Metis Global Partners, LLC | added | 1.23 | 292,817 | 2,519,490 | 0.09% |
May 06, 2024 | Manchester Capital Management LLC | added | 27.42 | 3,264 | 10,958 | -% |
May 06, 2024 | Ifrah Financial Services, Inc. | reduced | -2.09 | 24,160 | 279,770 | 0.08% |
May 06, 2024 | Spectrum Wealth Counsel, LLC | unchanged | - | 73.00 | 694 | -% |
May 06, 2024 | NEW YORK LIFE INVESTMENT MANAGEMENT LLC | reduced | -3.54 | 586,569 | 8,090,790 | 0.08% |
May 06, 2024 | TEXAS PERMANENT SCHOOL FUND CORP | reduced | -0.11 | 1,153,780 | 11,053,600 | 0.09% |
May 06, 2024 | Integrated Advisors Network LLC | reduced | -11.28 | -5,905 | 709,375 | 0.04% |
May 06, 2024 | DUALITY ADVISERS, LP | sold off | -100 | -5,127,520 | - | -% |
May 06, 2024 | Parallel Advisors, LLC | added | 14.56 | 125,515 | 573,108 | 0.02% |
May 06, 2024 | Bard Financial Services, Inc. | unchanged | - | 24,837 | 235,790 | 0.03% |
Unveiling DexCom Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to DexCom Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
ABT | 184.5B | 40.3B | 32.81 | 4.58 | ||||
BDX | 68.5B | 19.7B | 51.42 | 3.48 | ||||
ALGN | 21.6B | 3.9B | 46.66 | 5.51 | ||||
BAX | 18.4B | 14.9B | 6.95 | 1.24 | ||||
MID-CAP | ||||||||
ATR | 9.9B | 3.5B | 31.71 | 2.8 | ||||
HSIC | 9.1B | 12.5B | 23.5 | 0.73 | ||||
BIO | 8.2B | 2.7B | -12.81 | 3.06 | ||||
XRAY | 5.9B | 3.9B | -62.76 | 1.49 | ||||
AXNX | 3.4B | 387.1M | -215.76 | 8.88 | ||||
PDCO | 2.3B | 6.6B | 12.05 | 0.35 | ||||
SMALL-CAP | ||||||||
AHCO | 1.3B | 3.2B | -1.87 | 0.4 | ||||
ANIK | 420.5M | 166.7M | -5.09 | 2.52 | ||||
ANGO | 245.9M | 324.0M | -1.28 | 0.76 | ||||
APYX | 48.8M | 52.3M | -2.61 | 0.93 | ||||
AEMD | 3.4M | 3.7M | -0.27 | 0.89 |
DexCom Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Revenue | -11.0% | 921 | 1,035 | 975 | 871 | 742 | 815 | 770 | 696 | 629 | 698 | 650 | 595 | 505 | 569 | 501 | 452 | 405 | 463 | 396 | 336 | 281 |
Gross Profit | -14.4% | 562 | 657 | 623 | 546 | 463 | 541 | 494 | 450 | 398 | 473 | 447 | 417 | 344 | 399 | 340 | 284 | 257 | 309 | 247 | 207 | 169 |
Operating Expenses | 4.8% | 461 | 440 | 418 | 418 | 415 | 416 | 347 | 373 | 357 | 472 | 329 | 316 | 298 | 295 | 246 | 216 | 223 | 208 | 191 | 207 | 183 |
S&GA Expenses | 3.7% | 319 | 308 | 285 | 297 | 296 | 305 | 235 | 249 | 219 | 237 | 199 | 187 | 189 | 173 | 159 | 136 | 150 | 129 | 124 | 138 | 124 |
R&D Expenses | 4.0% | 142 | 136 | 131 | 119 | 119 | 116 | 110 | 122 | 136 | 150 | 129 | 129 | 109 | 119 | 88.00 | 80.00 | 73.00 | 79.00 | 67.00 | 69.00 | 59.00 |
EBITDA Margin | 3.6% | 0.26* | 0.25* | 0.23* | 0.21* | 0.20* | 0.19* | 0.15* | 0.14* | 0.15* | 0.15* | 0.20* | 0.20* | - | - | - | - | - | - | - | - | - |
Interest Expenses | - | 5.00 | - | - | 6.00 | 5.00 | -1.70 | 5.00 | 5.00 | 5.00 | -2.50 | 5.00 | 5.00 | 5.00 | -42.40 | 24.00 | 20.00 | 15.00 | 15.00 | 15.00 | 15.00 | 15.00 |
Income Taxes | -37.6% | -13.90 | -10.10 | 120 | 43.00 | 16.00 | 41.00 | 45.00 | 24.00 | -61.20 | 12.00 | 25.00 | 19.00 | -15.20 | -257 | 3.00 | -0.10 | 3.00 | 2.00 | - | 1.00 | 0.00 |
Earnings Before Taxes | -46.2% | 133 | 246 | 240 | 159 | 65.00 | 133 | 146 | 75.00 | 36.00 | 6.00 | 112 | 97.00 | 41.00 | 154 | 75.00 | 46.00 | 22.00 | 94.00 | 46.00 | -9.30 | -26.60 |
EBT Margin | 4.4% | 0.20* | 0.20* | 0.18* | 0.16* | 0.14* | 0.13* | 0.09* | 0.09* | 0.10* | 0.10* | 0.17* | 0.17* | - | - | - | - | - | - | - | - | - |
Net Income | -42.9% | 146 | 256 | 121 | 116 | 49.00 | 92.00 | 101 | 51.00 | 97.00 | -5.30 | 87.00 | 78.00 | 57.00 | 411 | 72.00 | 46.00 | 20.00 | 93.00 | 46.00 | -10.50 | -26.90 |
Net Income Margin | 12.5% | 0.17* | 0.15* | 0.11* | 0.11* | 0.10* | 0.12* | 0.09* | 0.09* | 0.10* | 0.09* | 0.27* | 0.28* | - | - | - | - | - | - | - | - | - |
Free Cashflow | 87.8% | 152 | 81.00 | 219 | 131 | 81.00 | 69.00 | 185 | 81.00 | -30.60 | 26.00 | 139 | -39.60 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | 3.5% | 6,482 | 6,265 | 6,596 | 6,821 | 5,516 | 5,392 | 4,899 | 5,217 | 5,057 | 4,933 | 4,776 | 4,504 | 4,390 | 4,291 | 3,833 | 3,522 | 2,448 | 2,395 | 2,186 | 2,066 | 1,974 |
Current Assets | 4.4% | 4,621 | 4,426 | 4,698 | 5,003 | 3,767 | 3,669 | 3,399 | 3,809 | 3,747 | 3,684 | 3,656 | 3,474 | 3,445 | 3,425 | 3,237 | 3,033 | 1,996 | 1,969 | 1,816 | 1,744 | 1,691 |
Cash Equivalents | 50.3% | 851 | 566 | 644 | 1,195 | 623 | 643 | 698 | 735 | 716 | 1,053 | 1,444 | 1,159 | 734 | 818 | 674 | 530 | 585 | 446 | 396 | 709 | 1,285 |
Inventory | 5.3% | 589 | 560 | 499 | 421 | 366 | 307 | 311 | 340 | 342 | 357 | 351 | 319 | 290 | 235 | 201 | 165 | 142 | 120 | 120 | 118 | 101 |
Net PPE | - | - | - | - | - | 1,076 | 1,056 | 1,003 | 943 | 857 | 802 | 742 | 676 | 590 | 515 | 462 | 384 | 346 | 321 | 301 | 253 | 221 |
Goodwill | -7.9% | 23.00 | 25.00 | 25.00 | 26.00 | 26.00 | 26.00 | 25.00 | 26.00 | 27.00 | 27.00 | 24.00 | 19.00 | 19.00 | 19.00 | 19.00 | 19.00 | 19.00 | 19.00 | 18.00 | 19.00 | 19.00 |
Liabilities | 0.9% | 4,235 | 4,196 | 4,328 | 4,720 | 3,283 | 3,260 | 3,075 | 2,962 | 2,868 | 2,891 | 2,640 | 2,506 | 2,487 | 2,464 | 2,334 | 2,168 | 1,513 | 1,512 | 1,421 | 1,378 | 1,305 |
Current Liabilities | 2.5% | 1,594 | 1,556 | 1,679 | 2,070 | 1,865 | 1,839 | 901 | 807 | 711 | 721 | 735 | 601 | 604 | 614 | 506 | 400 | 343 | 360 | 322 | 288 | 235 |
Shareholder's Equity | 8.6% | 2,247 | 2,069 | 2,268 | 2,100 | 2,233 | 2,132 | 1,825 | 2,256 | 2,189 | 2,042 | 1,912 | 1,755 | 1,645 | 1,552 | 1,499 | 1,354 | 935 | 883 | 764 | 688 | 669 |
Retained Earnings | 14.3% | 1,168 | 1,021 | 765 | 644 | 529 | 480 | 388 | 287 | 236 | 139 | -28.00 | -98.90 | -161 | -78.20 | -557 | -629 | -675 | -695 | -788 | -834 | -823 |
Additional Paid-In Capital | -28.6% | 2,511 | 3,515 | 3,618 | 2,269 | 2,306 | 2,258 | 2,072 | 2,029 | 1,997 | 2,109 | 2,322 | 2,194 | 2,162 | 1,727 | 2,154 | 2,080 | 1,707 | 1,676 | 1,652 | 1,620 | 1,591 |
Shares Outstanding | 2.8% | 396 | 385 | 386 | 386 | 387 | 386 | 390 | 391 | 389 | 387 | 387 | 387 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | - | 49,400 | - | - | - | 29,100 | - | - | - | 41,100 | - | - | - | 38,500 | - | - | - | 13,557 | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | 56.6% | 209,200 | 133,600 | 269,200 | 190,300 | 155,400 | 132,500 | 293,200 | 172,800 | 71,000 | 105,800 | 247,300 | 61,600 | 27,800 | 172,000 | 147,600 | 154,100 | 1,900 | 143,700 | 94,500 | 64,500 | 11,800 |
Share Based Compensation | 5.7% | 39,000 | 36,900 | 39,000 | 39,700 | 35,200 | 34,000 | 30,800 | 32,600 | 29,100 | 26,300 | 27,500 | 31,600 | 28,000 | 34,100 | 30,700 | 30,700 | 23,900 | 23,600 | 24,400 | 29,700 | 25,000 |
Cashflow From Investing | -82.0% | 74,800 | 414,900 | -179,500 | -555,900 | -186,700 | -194,100 | 229,300 | -144,900 | -411,800 | -496,100 | 29,000 | 363,200 | -112,200 | -24,000 | -9,300 | -1,115,300 | 130,600 | -94,300 | -412,800 | -639,400 | 131,300 |
Cashflow From Financing | 100.7% | 4,700 | -631,900 | -637,400 | 939,500 | 11,200 | -1,000 | -552,500 | -4,300 | 5,300 | -800 | 10,800 | -400 | 800 | -4,900 | 4,500 | 906,000 | 6,500 | -100 | 6,000 | -100 | 4,900 |
Buy Backs | -100.0% | - | 500,000 | - | - | - | - | 557,700 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Consolidated Statements of Operations (Unaudited) - USD ($) shares in Millions, $ in Millions | 3 Months Ended | |
---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | |
Income Statement [Abstract] | ||
Revenue | $ 921.0 | $ 741.5 |
Cost of sales | 359.1 | 278.9 |
Gross profit | 561.9 | 462.6 |
Operating expenses: | ||
Research and development | 141.5 | 119.0 |
Selling, general and administrative | 319.3 | 296.4 |
Total operating expenses | 460.8 | 415.4 |
Operating income | 101.1 | 47.2 |
Other income (expense), net | 31.4 | 17.3 |
Income before income taxes | 132.5 | 64.5 |
Income tax expense (benefit) | (13.9) | 15.9 |
Net income | $ 146.4 | $ 48.6 |
Basic net income per share (in USD per share) | $ 0.38 | $ 0.13 |
Shares used to compute basic net income per share (in shares) | 390.2 | 386.7 |
Diluted net income per share (in USD per share) | $ 0.36 | $ 0.12 |
Shares used to compute diluted net income per share (in shares) | 416.7 | 418.5 |
Consolidated Balance Sheets (Unaudited) - USD ($) $ in Millions | Mar. 31, 2024 | Dec. 31, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 851.2 | $ 566.3 |
Short-term marketable securities | 2,045.8 | 2,157.8 |
Accounts receivable, net | 978.6 | 973.9 |
Inventory | 589.1 | 559.6 |
Prepaid and other current assets | 156.0 | 168.3 |
Total current assets | 4,620.7 | 4,425.9 |
Property and equipment, net | 1,108.6 | 1,113.1 |
Operating lease right-of-use assets | 68.0 | 71.4 |
Goodwill | 23.2 | 25.2 |
Intangibles, net | 123.3 | 134.5 |
Deferred tax assets | 460.7 | 419.4 |
Other assets | 77.7 | 75.0 |
Total assets | 6,482.2 | 6,264.5 |
Current liabilities: | ||
Accounts payable and accrued liabilities | 1,446.6 | 1,345.5 |
Accrued payroll and related expenses | 110.5 | 171.0 |
Short-term operating lease liabilities | 20.7 | 21.1 |
Deferred revenue | 16.4 | 18.4 |
Total current liabilities | 1,594.2 | 1,556.0 |
Long-term senior convertible notes | 2,436.0 | 2,434.2 |
Long-term operating lease liabilities | 75.8 | 80.1 |
Other long-term liabilities | 129.4 | 125.6 |
Total liabilities | 4,235.4 | 4,195.9 |
Commitments and contingencies | ||
Stockholders’ equity: | ||
Preferred stock, $0.001 par value, 5.0 million shares authorized; no shares issued and outstanding at March 31, 2024 and December 31, 2023 | 0.0 | 0.0 |
Common stock, $0.001 par value, 800.0 million shares authorized; 408.5 million and 396.1 million shares issued and outstanding, respectively, at March 31, 2024; and 407.2 million and 385.4 million shares issued and outstanding, respectively, at December 31, 2023 | 0.4 | 0.4 |
Additional paid-in capital | 2,510.6 | 3,514.6 |
Accumulated other comprehensive loss | (37.3) | (16.7) |
Retained earnings | 1,167.8 | 1,021.4 |
Treasury stock, at cost; 12.4 million shares at March 31, 2024 and 21.8 million shares at December 31, 2023 | (1,394.7) | (2,451.1) |
Total stockholders’ equity | 2,246.8 | 2,068.6 |
Total liabilities and stockholders’ equity | $ 6,482.2 | $ 6,264.5 |